Gluten-free Diet Reduces the Risk of Irritable Bowel Syndrome: A Mendelian Randomization Analysis
Open Access
- 9 November 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 12
Abstract
Background: Whether a gluten-free diet (GFD) is a cause of irritable bowel syndrome (IBS) remains controversial. We aim at exploring the causal relationship between gluten intake and IBS within Mendelian randomization (MR) design.Methods: We conducted a two-sample MR and selected single-nucleotide polymorphisms (SNPs) associated with GFD as instrumental variables (IVs). SNPs and genetic associations with GFD and IBS were obtained from the latest genome-wide association studies (GWAS) in Europeans (GFD: cases: 1,376; controls: 63,573; IBS: cases:1,121; controls: 360,073). We performed inverse variance weighting (IVW) as the primary method with several sensitivity analyses like MR-Egger and MR-PRESSO for quality control. The above analyses were re-run using another large dataset of IBS, as well as changing the p-value threshold when screening IVs, to verify the stability of the results.Results: The final estimate indicated significant causal association [per one copy of effect allele predicted log odds ratio (OR) change in GFD intake: OR = 0.97, 95% confidence interval (CI) 0.96 to 0.99, p < 0.01] without heterogeneity statistically (Q = 2.48, p = 0.78) nor horizontal pleiotropy biasing the causality (p = 0.92). Consistent results were found in validation analyses. Results of MR Steiger directionality test indicated the accuracy of our estimate of the causal direction (Steiger p < 0.001).Conclusion: GFD might be a protective factor of IBS. Therefore, we suggest taking a diet of lower gluten intake into account in IBS prevention and clinical practice.Keywords
This publication has 53 references indexed in Scilit:
- Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable EstimatorsAmerican Journal of Epidemiology, 2013
- Development and evaluation of the Oxford WebQ, a low-cost, web-based method for assessment of previous 24 h dietary intakes in large-scale prospective studiesPublic Health Nutrition, 2011
- Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactionsNature Reviews Gastroenterology & Hepatology, 2010
- Between Celiac Disease and Irritable Bowel Syndrome: The “No Man's Land” of Gluten SensitivityAmerican Journal of Gastroenterology, 2009
- Mendelian randomization: Using genes as instruments for making causal inferences in epidemiologyStatistics in Medicine, 2008
- Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trialGut, 2004
- Postinfectious irritable bowel syndrome1 1Abbreviations used in this paper: EC,_; IBS, irritable bowel syndrome; PI, postinfective.Gastroenterology, 2003
- Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndromeGut, 2003
- Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndromeGut, 2000
- Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patientsBMJ, 1997